Poultry Vaccines Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	400 Pages	BlueWeave Consulting	August, 2023	BLWC18132161

Best Price Guarantee
Price	from $4,850
Length	400 Pages
Publisher	BlueWeave Consulting
Published Date	August, 2023
SKU	BLWC18132161

Poultry Vaccines Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product Type (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines); By Dosage Form (Liquid Vaccine, Freeze Dried Vaccine, Duct); By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian, Encephalomyelitis, Fowl Cholera); By Application (Broiler, Layer, Breeder); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Poultry Vaccines Market Size Set to Touch USD 3.9 Billion by 2029

Global poultry vaccines market is flourishing because of the rising technological advancements by market players and increasing R&D activities associated with poultry vaccines.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global poultry vaccines market size at USD 2.763 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global poultry vaccines market size to grow at a significant CAGR of 5.7% reaching a value of USD 3.857 billion by 2029. Major growth drivers for the global poultry vaccines market include an increasing poultry production, rising demand for poultry products, and growing awareness about the importance of vaccination in disease prevention. The expanding poultry population and the increasing prevalence of avian diseases are expected to further drive the demand for poultry vaccines. To mitigate the risks associated with infected meat consumption and the challenges faced by poultry farms, vaccination plays a crucial role in disease prevention. In 2019, the United States had 19.72 million livestock units of chickens, while Brazil had 14.6 million livestock units, highlighting the considerable number of susceptible birds that could benefit from timely vaccinations. According to the OIE-WAHIS database, there were only 22 new bird outbreaks within a specific period, but this number drastically surged to 836 outbreaks in 2020, with an estimated 2.79 million cases. This significant rise in disease outbreaks among the avian population serves as a key driver for the poultry vaccines market. However, side-effects of poultry vaccines and high costs and limited access are anticipated to restrain the overall market growth during the period in analysis.

Global Poultry Vaccines Market – Overview

The global poultry vaccines market refers to the worldwide market for vaccines specifically developed for poultry species. Poultry vaccines are used to prevent and control various diseases that affect poultry, including viral, bacterial, and parasitic infections. The market encompasses the research, development, production, and distribution of these vaccines. It plays a crucial role in maintaining the health and productivity of poultry populations, supporting the sustainable growth of the poultry industry. The global poultry vaccines market is driven by increasing poultry production, rising demand for poultry products, and growing awareness of the importance of vaccination in disease prevention.

Impact of COVID-19 on Global Poultry Vaccines Market

COVID-19 pandemic had a mixed impact on the global poultry vaccines market. On the one hand, there was an increased focus on food safety and biosecurity, which heightened the importance of disease prevention measures, including vaccination, leading to a surge in demand for poultry vaccines. On the other hand, disruptions in the supply chain, restrictions on international trade, and reduced poultry production in some regions posed challenges to the market. Additionally, the diversion of resources toward human health during the pandemic affected R&D activities in the field.

Global Poultry Vaccines Market – By Application

Based on application, the global poultry vaccines market is divided into Broiler, Layer, and Breeder segments. The breeder segment held the highest market share in 2022 by application due to the increasing number of breeder farms that produce fertile eggs for hatcheries. The enhanced productivity achieved through these breeding farms has greatly contributed to the market's expansion. Government initiatives aimed at vaccinating breeders have played a significant role in driving market growth. Vaccinating breeders not only safeguards the vaccinated birds but also protects the progeny, including broilers. Proactive government policies have resulted in the growth of poultry farmers, breeders, integrators, and feed mills. For example, the Animal Husbandry Department in the state of Andhra Pradesh, India implemented a comprehensive poultry development policy (2016-2020), stimulating production in the poultry sector, promoting egg and chicken processing, and facilitating export activities. Such favorable government initiatives continue to propel the market's growth. Additionally, the market benefits from a favorable regulatory environment and supportive measures that promote sustainable poultry farming practices and ensure food security.

Competitive Landscape

Major players operating in the global poultry vaccines market include Boehringer Ingelheim International GmbH, Ceva, Zoetis, Elanco, Merck & Co., Inc., Hester Biosciences Limited, Vaxxinova International BV, Venkys India, Calier, KM Biologics, and Phibro Animal Health Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Poultry Vaccines Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Poultry Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

1. Research Framework: 1.1. Research Objective; 1.2. Product Overview; 1.3. Market Segmentation
2. Executive Summary
3. Global Poultry Vaccines Market Insights: 3.1. Industry Value Chain Analysis; 3.2. DROC Analysis; 3.2.1. Growth Drivers; 3.2.1.1. Increasing Research Activities Associated with Poultry vaccines; 3.2.1.2. Huge Technological Advancements by Market Players; 3.2.2. Restraints; 3.2.2.1. Side-Effects of Poultry Vaccines; 3.2.2.2. High Costs and Limited Access; 3.2.3. Opportunities; 3.2.3.1. Increasing Prevalence of Avian Influenza; 3.2.3.2. Increasing Usage of Inactivated Vaccines; 3.2.4. Challenges; 3.2.4.1. Antigenic Variation of Diseases; 3.2.4.2. Cold Chain Management; 3.3. Technological Advancements/Recent Developments; 3.4. Regulatory Framework; 3.5. Porter’s Five Forces Analysis; 3.5.1. Bargaining Power of Suppliers; 3.5.2. Bargaining Power of Buyers; 3.5.3. Threat of New Entrants; 3.5.4. Threat of Substitutes; 3.5.5. Intensity of Rivalry
4. Global Poultry Vaccines Market Overview: 4.1. Market Size & Forecast, 2019–2029; 4.1.1. By Value (USD Billion); 4.2. Market Share and Forecast; 4.2.1. By Product Type; 4.2.1.1. Attenuated Live Vaccines; 4.2.1.2. Inactivated Vaccines; 4.2.1.3. Subunit Vaccines; 4.2.1.4. DNA Vaccines; 4.2.1.5. Recombinant Vaccines; 4.2.2. By Dosage Form; 4.2.2.1. Liquid Vaccine; 4.2.2.2. Freeze Dried Vaccine; 4.2.2.3. Duct; 4.2.3. By Disease Type; 4.2.3.1. Infectious Bronchitis; 4.2.3.2. Infectious Bursal Diseases; 4.2.3.3. Infectious Laryngotracheitis; 4.2.3.4. Egg Drop Syndrome; 4.2.3.5. Adenovirus; 4.2.3.6. Duck Viral Enteritis; 4.2.3.7. Inclusion Body Hepatitis; 4.2.3.8. Coccidiosis; 4.2.3.9. Avian Influenza; 4.2.3.10. Marek's Disease; 4.2.3.11. Newcastle Disease; 4.2.3.12. Salmonella; 4.2.3.13. Avian Encephalomyelitis; 4.2.3.14. Fowl Cholera; 4.2.4. By Application; 4.2.4.1. Broiler; 4.2.4.2. Layer; 4.2.4.3. Breeder; 4.2.5. By Region; 4.2.5.1. North America; 4.2.5.2. Europe; 4.2.5.3. Asia Pacific (APAC); 4.2.5.4. Latin America (LATAM); 4.2.5.5. Middle East and Africa (MEA)
5. North America Poultry Vaccines Market: 5.1. Market Size & Forecast, 2019–2029; 5.1.1. By Value (USD Billion); 5.2. Market Share & Forecast; 5.2.1. By Product Type; 5.2.2. By Dosage Form; 5.2.3. By Disease Type; 5.2.4. By Application; 5.2.5. By Country; 5.2.5.1. United States; 5.2.5.1.1. By Product Type; 5.2.5.1.2. By Dosage Form; 5.2.5.1.3. By Disease Type; 5.2.5.1.4. By Application; 5.2.5.2. Canada; 5.2.5.2.1. By Product Type; 5.2.5.2.2. By Dosage Form; 5.2.5.2.3. By Disease Type; 5.2.5.2.4. By Application
6. Europe Poultry Vaccines Market: 6.1. Market Size & Forecast, 2019–2029; 6.1.1. By Value (USD Billion); 6.2. Market Share & Forecast; 6.2.1. By Product Type; 6.2.2. By Dosage Form; 6.2.3. By Disease Type; 6.2.4. By Application; 6.2.5. By Country; 6.2.5.1. Germany; 6.2.5.1.1. By Product Type; 6.2.5.1.2. By Dosage Form; 6.2.5.1.3. By Disease Type; 6.2.5.1.4. By Application; 6.2.5.2. United Kingdom; 6.2.5.2.1. By Product Type; 6.2.5.2.2. By Dosage Form; 6.2.5.2.3. By Disease Type; 6.2.5.2.4. By Application; 6.2.5.3. Italy; 6.2.5.3.1. By Product Type; 6.2.5.3.2. By Dosage Form; 6.2.5.3.3. By Disease Type; 6.2.5.3.4. By Application; 6.2.5.4. France; 6.2.5.4.1. By Product Type; 6.2.5.4.2. By Dosage Form; 6.2.5.4.3. By Disease Type; 6.2.5.4.4. By Application; 6.2.5.5. Spain; 6.2.5.5.1. By Product Type; 6.2.5.5.2. By Dosage Form; 6.2.5.5.3. By Disease Type; 6.2.5.5.4. By Application; 6.2.5.6. Belgium; 6.2.5.6.1. By Product Type; 6.2.5.6.2. By Dosage Form; 6.2.5.6.3. By Disease Type; 6.2.5.6.4. By Application; 6.2.5.7. Russia; 6.2.5.7.1. By Product Type; 6.2.5.7.2. By Dosage Form; 6.2.5.7.3. By Disease Type; 6.2.5.7.4. By Application; 6.2.5.8. The Netherlands; 6.2.5.8.1. By Product Type; 6.2.5.8.2. By Dosage Form; 6.2.5.8.3. By Disease Type; 6.2.5.8.4. By Application; 6.2.5.9. Rest of Europe; 6.2.5.9.1. By Product Type; 6.2.5.9.2. By Dosage Form; 6.2.5.9.3. By Disease Type; 6.2.5.9.4. By Application
7. Asia-Pacific Poultry Vaccines Market: 7.1. Market Size & Forecast, 2019–2029; 7.1.1. By Value (USD Billion); 7.2. Market Share & Forecast; 7.2.1. By Product Type; 7.2.2. By Dosage Form; 7.2.3. By Disease Type; 7.2.4. By Application; 7.2.5. By Country; 7.2.5.1. China; 7.2.5.1.1. By Product Type; 7.2.5.1.2. By Dosage Form; 7.2.5.1.3. By Disease Type; 7.2.5.1.4. By Application; 7.2.5.2. India; 7.2.5.2.1. By Product Type; 7.2.5.2.2. By Dosage Form; 7.2.5.2.3. By Disease Type; 7.2.5.2.4. By Application; 7.2.5.3. Japan; 7.2.5.3.1. By Product Type; 7.2.5.3.2. By Dosage Form; 7.2.5.3.3. By Disease Type; 7.2.5.3.4. By Application; 7.2.5.4. South Korea; 7.2.5.4.1. By Product Type; 7.2.5.4.2. By Dosage Form; 7.2.5.4.3. By Disease Type; 7.2.5.4.4. By Application; 7.2.5.5. Australia & New Zealand; 7.2.5.5.1. By Product Type; 7.2.5.5.2. By Dosage Form; 7.2.5.5.3. By Disease Type; 7.2.5.5.4. By Application; 7.2.5.6. Indonesia; 7.2.5.6.1. By Product Type; 7.2.5.6.2. By Dosage Form; 7.2.5.6.3. By Disease Type; 7.2.5.6.4. By Application; 7.2.5.7. Malaysia; 7.2.5.7.1. By Product Type; 7.2.5.7.2. By Dosage Form; 7.2.5.7.3. By Disease Type; 7.2.5.7.4. By Application; 7.2.5.8. Singapore; 7.2.5.8.1. By Product Type; 7.2.5.8.2. By Dosage Form; 7.2.5.8.3. By Disease Type; 7.2.5.8.4. By Application; 7.2.5.9. Vietnam; 7.2.5.9.1. By Product Type; 7.2.5.9.2. By Dosage Form; 7.2.5.9.3. By Disease Type; 7.2.5.9.4. By Application; 7.2.5.10. Rest of APAC; 7.2.5.10.1. By Product Type; 7.2.5.10.2. By Dosage Form; 7.2.5.10.3. By Disease Type; 7.2.5.10.4. By Application
8. Latin America Poultry Vaccines Market: 8.1. Market Size & Forecast, 2019–2029; 8.1.1. By Value (USD Billion); 8.2. Market Share & Forecast; 8.2.1. By Product Type; 8.2.2. By Dosage Form; 8.2.3. By Disease Type; 8.2.4. By Application; 8.2.5. By Country; 8.2.5.1. Brazil; 8.2.5.1.1. By Product Type; 8.2.5.1.2. By Dosage Form; 8.2.5.1.3. By Disease Type; 8.2.5.1.4. By Application; 8.2.5.2. Mexico; 8.2.5.2.1. By Product Type; 8.2.5.2.2. By Dosage Form; 8.2.5.2.3. By Disease Type; 8.2.5.2.4. By Application; 8.2.5.3. Argentina; 8.2.5.3.1. By Product Type; 8.2.5.3.2. By Dosage Form; 8.2.5.3.3. By Disease Type; 8.2.5.3.4. By Application; 8.2.5.4. Peru; 8.2.5.4.1. By Product Type; 8.2.5.4.2. By Dosage Form; 8.2.5.4.3. By Disease Type; 8.2.5.4.4. By Application; 8.2.5.5. Rest of LATAM; 8.2.5.5.1. By Product Type; 8.2.5.5.2. By Dosage Form; 8.2.5.5.3. By Disease Type; 8.2.5.5.4. By Application
9. Middle East & Africa Poultry Vaccines Market: 9.1. Market Size & Forecast, 2019–2029; 9.1.1. By Value (USD Billion); 9.2. Market Share & Forecast; 9.2.1. By Product Type; 9.2.2. By Dosage Form; 9.2.3. By Disease Type; 9.2.4. By Application; 9.2.5. By Country; 9.2.5.1. Saudi Arabia; 9.2.5.1.1. By Product Type; 9.2.5.1.2. By Dosage Form; 9.2.5.1.3. By Disease Type; 9.2.5.1.4. By Application; 9.2.5.2. UAE; 9.2.5.2.1. By Product Type; 9.2.5.2.2. By Dosage Form; 9.2.5.2.3. By Disease Type; 9.2.5.2.4. By Application; 9.2.5.3. Qatar; 9.2.5.3.1. By Product Type; 9.2.5.3.2. By Dosage Form; 9.2.5.3.3. By Disease Type; 9.2.5.3.4. By Application; 9.2.5.4. Kuwait; 9.2.5.4.1. By Product Type; 9.2.5.4.2. By Dosage Form; 9.2.5.4.3. By Disease Type; 9.2.5.4.4. By Application; 9.2.5.5. South Africa; 9.2.5.5.1. By Product Type; 9.2.5.5.2. By Dosage Form; 9.2.5.5.3. By Disease Type; 9.2.5.5.4. By Application; 9.2.5.6. Nigeria; 9.2.5.6.1. By Product Type; 9.2.5.6.2. By Dosage Form; 9.2.5.6.3. By Disease Type; 9.2.5.6.4. By Application; 9.2.5.7. Algeria; 9.2.5.7.1. By Product Type; 9.2.5.7.2. By Dosage Form; 9.2.5.7.3. By Disease Type; 9.2.5.7.4. By Application; 9.2.5.8. Rest of MEA; 9.2.5.8.1. By Product Type; 9.2.5.8.2. By Dosage Form; 9.2.5.8.3. By Disease Type; 9.2.5.8.4. By Application
10. Competitive Landscape: 10.1. List of Key Players and Their Offerings; 10.2. Global Poultry Vaccines Market Share Analysis, 2022; 10.3. Competitive Benchmarking, By Operating Parameters; 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Poultry Vaccines Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis): 12.1. Boehringer Ingelheim International GmbH; 12.2. Ceva; 12.3. Zoetis; 12.4. Elanco; 12.5. Merck & Co., Inc.; 12.6. Hester Biosciences Limited; 12.7. Vaxxinova International BV; 12.8. Venkys India; 12.9. Calier; 12.10. KM Biologics; 12.11. Phibro Animal Health Corporation; 12.12. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology: 14.1. Qualitative Research; 14.1.1. Primary & Secondary Research; 14.2. Quantitative Research; 14.3. Market Breakdown & Data Triangulation; 14.3.1. Secondary Research; 14.3.2. Primary Research; 14.4. Breakdown of Primary Research Respondents, By Region; 14.5. Assumptions & Limitations